Ivermectin
Prof Alistair Nichol (Dublin & Melbourne) discusses the latest controversial investigative agent to be added to the REMAP-CAP platform trial - ivermectin
Behind the Scenes
Dr Lennie Derde (Utrecht) talks about the running of the REMAP-CAP trial, including her roles as Chair of the international Trial Steering Committee and European Coordinating Investigator
Ivermectin
Prof Derek Angus (Pittsburgh) discusses the concept of a learning healthcare system and how this relates to the REMAP-CAP trial
The Great Pandemic of 2020
Prof Mathias Schultz from Jena, Germany, discusses pandemics, the current coronavirus pandemic, and the role of the REMAP-CAP trial in combating this global threat
The Ventilator
Prof Alistair Nichol (Dublin & Melbourne) discusses the new ventilator domain soon to be launched as part of the greater REMAP-CAP trial
The Chosen Interventions
Srin Murthy and John Marshall from Canada discuss the interventiosns chosen to be tested in the REMAP-CAP adaptive platform trial
The Complexity
Scott Berry, from Berry Consulting, describes the phenomenal Bayesian framework which underlies the complexity of this groundbreaking trial design
The Beginning
Steve Webb, one the original investigators, recounts the origins and growth of REMAP-CAP, including the constant addition of new investigators and sites to the REMAP-CAP Family